Micardis HCT (Boehringer Ingelheim Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Micardis HCT drug offered from Boehringer Ingelheim Pharmaceuticals, Inc.. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | telmisartan and hydrochlorothiazide |
| SUBSTANCE NAME: | TELMISARTAN; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2000-12-01 |
| END MARKETING DATE: | 0000-00-00 |
Micardis HCT HUMAN PRESCRIPTION DRUG Details:
| Item Description | Micardis HCT from Boehringer Ingelheim Pharmaceuticals, Inc. |
| LABELER NAME: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 80; 25(mg/1; mg/1) |
| START MARKETING DATE: | 2000-12-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0597-0042_65efa704-8f9c-4086-5c36-a8e1ad0bb9ec |
| PRODUCT NDC: | 0597-0042 |
| APPLICATION NUMBER: | NDA021162 |
Other TELMISARTAN; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
